143557-91-9

Basic information

• Product Name: tert-butyl 3-endo-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate
• Synonyms: tert-butyl 3-endo-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate;N-Boc-Nortropine;tert-Butyl 3-endo-3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate;(3-endo)-3-Hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylic acid tert-butyl ester;endo-3-Hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylic acid 1,1-dimethylethyl ester;N-tert-Butoxycarbonylnortropan-3-ol;endo-8-Boc-3-hydroxy-8-azabicyclo[3.2.1]octane;tert-butyl (1R,3r,5S)-3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate
• CAS NO: 143557-91-9
• Molecular Formula: C₁₂H₂₁NO₃
• Molecular Weight: 227.31
• Mol File: 143557-91-9.mol
• Article Data: 46

Chemical Properties

• Melting Point: 141.5℃
• Boiling Point: 328℃
• Flash Point: 152℃
• Appearance: /
• Density: 1.146
• Vapor Pressure: 1.48E-05mmHg at 25°C
• Refractive Index: 1.52
• Storage Temp.: 2-8°C
• PKA: 14.79±0.20(Predicted)
• CAS DataBase Reference: tert-butyl 3-endo-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 3-endo-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate(143557-91-9)
• EPA Substance Registry System: tert-butyl 3-endo-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate(143557-91-9)

Safety Data

• Statements: 22-36/37/38
• Safety Statements: 22-26-36/37/39
• RIDADR: UN2811
• Hazardous Substances Data: 143557-91-9(Hazardous Substances Data)

Usage

General Description

Tert-butyl 3-endo-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate is a synthetic compound with a complex chemical structure. It contains a tert-butyl group, a hydroxyl group, and a carboxylate group, as well as a bicyclic ring system with nitrogen. tert-butyl 3-endo-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate may be used in the development of pharmaceuticals or as a research tool in chemical and biological studies. Its unique structure gives it potential for specific interactions with biological systems, making it a valuable molecule for further exploration and potential applications in the pharmaceutical industry.

InChI:InChI=1/C12H21NO3/c1-12(2,3)16-11(15)13-8-4-5-9(13)7-10(14)6-8/h8-10,14H,4-7H2,1-3H3

Upstream product

• 185099-67-6 Boc-tropinone 
• 185099-67-6 N-Boc-nortropinone 
• 652148-00-0 8-(4-fluoro-benzyl)-8-aza-bicyclo[3.2.1]octan-3-ol 
• 34619-03-9 tert-butyldicarbonate 
• 120-29-6 3-tropanol 
• 538-09-0 nortropine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 28957-72-4 N-benzyltropinone 
• 542-05-2 acetonedicarboxylic acid 
• 7432-10-2 Tropanol 
• 28957-72-4 N-benzylnortropinone 
• 813420-07-4 3-benzoyloxy-8-azabicyclo[3.2.1 ]octane-8-carboxylic acid 2,2,2-trichloroethyl ester 
• 19145-60-9 endo-benzoic acid 8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl ester 
• 18470-33-2 3β-benzoyloxy-8-azabicyclo[3.2.1]octane 

Downstream Products

• 1320346-15-3 exo-tert-butyl 3-(3-methoxy-2-oxo-chromen-7-yl)oxy-8-azabicyclo[3.2.1]octane-8-carboxylate 
• 1267849-02-4 tert-butyl (1R,3r,5S)-3-(4-cyanophenoxy)-8-azabicyclo[3.2.1]octane-8-carboxylate 
• 1307255-31-7 C₁₈H₂₃ClFNO₃ 
• 744183-20-8 tert-butyl (1R,3s,5S)-3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate 
• 1307254-46-1 tert-Butyl (3-exo)-3-[benzyl(methyl)amino]-8-azabicyclo[3.2.1]octane-8-carboxylate 
• 1307254-44-9 tert-butyl (1R,3s,5S)-3-(((benzyloxy)carbonyl)(methyl)amino)-8-azabicyclo[3.2.1]octane-8-carboxylate 
• 1307254-80-3 tert-butyl (3-endo)-3-[3-(2-methoxyethyl)phenoxy]-8-azabicyclo[3.2.1]octane-8-carboxylate 
• 1307255-28-2 C₂₄H₃₀N₂O₄ 
• 1307255-32-8 C₁₈H₂₄FNO₄ 
• 1307255-33-9 tert-butyl (3-endo)-3-[3-(difluoromethoxy)-4-fluorophenoxy]-8-azabicyclo[3.2.1]octane-8-carboxylate 
• 1307255-04-4 C₁₈H₂₃ClN₂O₅ 
• 1182356-97-3 (Endo)-3-[3-(2-fluorophenyl)propoxy]-8-azabicyclo[3.2.1]octane-8-carboxylic acid tert-butyl ester 
• 1182356-99-5 (Endo)-3-(4-methylbenzyloxy)-8-azabicyclo[3.2.1]octane-8-carboxylic acid tert-butyl ester 
• 797763-47-4 3α-(1-azidobenzyloxy)-8-azabicyclo[3.2.1]octane-8-carboxylic acid tert-butyl ester 

Relevant articles and documents

Bioorthogonal Self-Immolative Linker Based on Grob Fragmentation

A self-immolative bioorthogonal conditionally cleavable linker based on Grob fragmentation is described. It is derived from 1,3-aminocyclohexanols and allows the release of sulfonate-containing compounds in aqueous media. Modulation of the amine pKa promo

AZABENZIMIDAZOLE COMPOUNDS AND PHARMACEUTICAL

The purpose of the present invention is to provide compounds having an M3 PAM action. Examples of the present invention include azabenzimidazole compounds represented, for example, by formula [I], and pharmacologically acceptable salts thereof. These comp

MODULATION OF N-ACYLETHANOLAMINE-HYDROLYSING ACID AMIDASE (NAAA) FOR DISEASE TREATMENT

Pharmaceutical compositions make up a compound acting as inhibitor of N-acylethanolamine-hydrolysing acid amidase (NAAA), may be used for the therapeutical treatment and prevention of pain and inflammatory disorders and other disorders which benefit from